On March 12, 2024, the Judicial Conference of the United States announced an amendment of the policy governing random case assignment to "deter[] judge-shopping."

Competition enforcement authorities in Italy and Portugal have been actively pursuing innovative approaches to antitrust matters, from creative merger remedies to groundbreaking research on artificial intelligence's impact on competitive markets. This conversation with the President of Portugal's Competition Authority explores recent developments in European competition law and the authority's efforts to expand consumer engagement beyond traditional metropolitan centers.

The FTC's record-setting $12 million settlement with Edwards Lifesciences and Genesis MedTech raises critical questions about deal structuring and Hart-Scott-Rodino Act compliance. When does strategic transaction design cross the line into intentional avoidance of premerger notification requirements? Leading antitrust practitioners examine the implications of this landmark enforcement action for deal teams navigating transactions near HSR thresholds.

Axinn antitrust group chair Mike Keeley, along with Slaughter & May partner Jordan Ellison in Brussels and JunHe LLP partner Janet Hui in Beijing shared their valuable insights and perspectives on how these political shifts impact regulatory frameworks and business strategies...

In this episode of Our Curious Amalgam podcast, Managing Partner Jeny Maier and co-host Jaclyn Phillips discuss with antitrust attorney Carla Hine the role private equity plays...

Jason Murata joins Richard Hsu on the Hsu Untied podcast to discuss his background in biochemistry and biotechnology...

Two weeks ago we discussed Vanda Pharmaceuticals' ambitious cert petition asking the Supreme Court to discontinue the "reasonable expectation of success" standard for patent...

M&A deals affecting the EU that fall outside standard merger control thresholds may still be subject to review under general competition law—but how does that work? In this episode, Axinn partner James Hunsberger and co-host Matthew Hall (McGuireWoods) explore the implications of the European Court of Justice’s 2023 “Towercast” judgment with guest Frédéric Manin (Advant Altana).

Managing partner Jeny Maier co-hosts this episode of Our Curious Amalgam with Sergei Zaslavsky (O'Melveny) and is joined by guest Dan Graulich (Baker & McKenzie )...

Axinn partner Lisl Dunlop joins hosts Alicia Downey and Rubin Waranch for an in-depth discussion on the growing wave of state-level transaction notification laws—often referred to as "mini-HSR laws.

How are public affairs strategies reshaping merger advocacy in today's regulatory environment? Managing Partner Jeny Maier and Nat Wood from Rational 360 explore the evolving playbook for strategic communications in M&A deals, examining how lobbying and public affairs intersect with antitrust considerations under current administrations.

Partner James Hunsberger appeared, along with Alicia Downey (Downey Law), Anora Wang (Arnold & Porter ), Brendan Coffman (Wilson Sonsini), Matthew Hall (McGuireWoods)...

When it comes to your health, having digitized information available for seamless sharing across multiple healthcare providers and other stakeholders -- including patients themselves -- is a clear benefit.

On this episode of Our Curious Amalgam, Axinn managing partner Jeny Maier speaks with Nuno Cunha Rodrigues, the president of the Portuguese Competition Authority, about his agency's competition enforcement priorities.

Axinn attorneys Jimmy Attridge, Brooke Oppenheimer, and Heather Zuckert co-authored the Competition Policy International article, "DOJ's Compliance Focus on Business Use of Communication...

Partner Lisl Dunlop speaks with Mark Seidman, partner at Weil Gotshal & Manges LLP, for the American Health Law Association's Speaking of Health Law podcast about some of the potential health care antitrust priorities of a second Trump Administration...

Amidst volatility in the marketplace and international trade, how can economics help us understand prices and underlying concepts such as cost pass-through?

Competition law has evolved from a specialized legal domain into a critical enterprise risk that demands board-level attention. How can corporate directors effectively oversee antitrust compliance and protect their companies from regulatory exposure in an era of heightened enforcement?

Every trial tells a story — but what happens when the storyteller becomes the judge? Managing Partner Jeny Maier joins Anora Wang as co-host for a wide-ranging conversation with the Honorable Judge Richard Franklin Boulware II about his extraordinary path from public defender to federal judge, and the lessons he's learned about persuasion, fairness, and the fine art of trial craft.

As we navigate the ever-evolving terrain of technology and market dynamics, it's vital to stay ahead with insights that transcend the moment. Partners Denise Plunkett and Bradley Justus...